Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Customer Access

Intellectual Property

Identifying Potentially Disruptive Inventions: Using metrics to identify key inventions in a large set of patents

By Nerac IP Analysts
Originally published November 13, 2018
It is important for companies working in areas of high technology to constantly be aware of new advances which may be disruptive to their operations. A number of metrics have been developed which can be used to evaluate individual patent families to identify those which represent potentially disruptive inventions. This paper will review some of those metrics and give a real world example of their use. Read the article here.

Maximizing the Potential of Licensing and Commercialization for Success

By Nerac IP Analysts
Originally published January 11, 2019
The commercialization landscape is filled with landmines and pitfalls; how do you navigate your way to a successful product launch? Or find a partner to launch your product with? This article explores the opportunities, and challenges, involved in the licensing and commercialization process. Read the article here.

How a Prior Art Search Will Actually Save Your Company Money

By Nerac IP Analysts
Originally published September 10, 2018
This article explores how to determine if there is any “prior art” out there which will prevent your company’s invention idea from being patentable, and how this can save you time and money! Read the article here.

Maximize R&D Resources with Patent Landscapes

By Nerac IP Analysts
Originally published March 27, 2018
This article explores the patent landscape in more detail, and looks at how the information gleaned from the analysis of a patent landscape can provide a company important insights to better understand their place in a given market space and help to make strategic decisions. Read more here.

Biosimilar “Patent Dance”

By Eden Joy Pacsial-Ong, Ph.D., Nerac Analyst/Patent Agent
Originally published September 26, 2017
This article explores the Biologics Price Competition and Innovations Act (BPCIA), a specific Supreme Court ruling and potential ramifications on the biologics industry. Read more here.